Views & Analysis | Perspectives on pharma industry issues

Skip to main content

Tuesday 15 September 2026

BlueSky linkedin youtube

header links

Get Newsletters
Media Kit

Pharmaphorum menu first category

News
Views & Analysis
Deep Dive
Webinars
Podcasts
Videos
Spotlight on
Events

close

SECTION

News
Views & Analysis
Deep Dive
Webinars
Podcasts
Videos
White Papers
Events

Channels

Channels

Sales & Marketing
R&D
Digital
Market Access
Oncology
Patients
Spotlight On

Channels

Sales & Marketing
R&D
Digital
Market Access
Oncology
Patients
Spotlight On

SUB NAVIGATION

Live Coverage
Partner Content
About us
Work for us
Contribute
Contact us
Advertise

Newsletters and Deep Dive digital magazine

youtube linkedin BlueSky

Sales & Marketing

Wooden pawns representing number of employees

Headcount is not a growth strategy

Deciding when, where, and how quickly to add headcount is rarely straightforward.

Market Access

pharmaphorum podcast Episode 275, Giancarlo Benelli, BeOne Medicines

Sponsored

Europe for life sciences and for patients, with BeOne Medici...

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Giancarlo Benelli, SVP & Head of Europe at BeOne Medicines.

R&D

Woman in black suit extends hand of welcome to the company

Changing Faces: Pharma and biotech hires, August 2026

August brought another wave of leadership changes across biotech, pharma, and research organisations.

R&D

Female scientists compares test tubes results

Trial complexity is the new normal

When operationalised effectively, RBQM can support earlier risk detection and more targeted quality improvement.

Sales & Marketing

Attendees and panel at a medical summit

Pharma's engagement problem: Are we expecting too much from ...

The question is no longer simply how to attract healthcare professionals to an event. The bigger challenge is how to create meaningful engagement.

Articles

Have we confirmed that controlling hyperglycaemia is not the magic bullet for preventing macrovascular disease in patients with type 2 diabetes?

Have we confirmed that controlling hyperglycaemia is not the...

Blair Hesp explores the benefits of controlling hyperglycaemia to prevent macrovascular disease in type 2 diabetes patients in our cardiovascular themed month.

Articles

From deployment to sustained usage: challenges faced by mHealth application developers

From deployment to sustained usage: challenges faced by mHea...

Mobile health, or mHealth, technology is on the increase.

Articles

Getting personal with mHealth

Getting personal with mHealth

As our mobile health focus continues, Morten Hjelmsoe shares his tips on applying the same patient-centric objectives to a mhealth strategy as you would to a digital communication strategy.

Load more results

Sales & Marketing

Sales & Marketing

Wooden pawns representing number of employees

Headcount is not a growth strategy

Deciding when, where, and how quickly to add headcount is rarely straightforward.

Sales & Marketing

Attendees and panel at a medical summit

Pharma's engagement problem: Are we expecting too much from ...

The question is no longer simply how to attract healthcare professionals to an event. The bigger challenge is how to create meaningful engagement.

Digital

Digital

AI in clinical rials and drug development

AI in clinical trials: Building better trials before they st...

With AI, trial sponsors are now reducing risk, accelerating timelines, and driving innovation by modelling what is most likely to work in the future.

Digital

pharmaphorum podcast Episode 274, Erik Janssen, UCB

Sponsored

Ethical AI & trust-driven innovation: UCB’s Erik Janssen

How can pharma lead the way in ethical AI and trust-driven innovation?

Market Access

Market Access

pharmaphorum podcast Episode 275, Giancarlo Benelli, BeOne Medicines

Sponsored

Europe for life sciences and for patients, with BeOne Medici...

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Giancarlo Benelli, SVP & Head of Europe at BeOne Medicines.

Market Access

Blue and white pills in pharma manufacturing line

Pharma’s most expensive question is the last one asked

Whether a drug can secure reimbursement is pharma's billion-dollar question, and the companies that succeed will be those that answer it sooner.

Editor's Picks

FDA overrides adcomm and approves AZ's oral SERD

Novartis falls sharply on another major R&D setback

Could UK clinical trial revamp unlock closer ties with Canada?

FDA makes acting CDER, CBER chiefs permanent

UK review recommends 'L plates' for new healthcare AIs

Newsletters and Deep Dive
digital magazine

Get Newsletters

Get in-depth news, opinions, and features on pharma and healthcare sent straight to your inbox

Oncology

Oncology

How today’s biotechs are helping us Stand Up To Cancer

In recognition of Stand Up To Cancer Day, a look at next-generation treatments that are on the verge of making it into clinical practice.

Oncology

Representation of embryonic stem cells

Bridging the innovation gap: Scalable cell therapies, adapti...

Biotech must build manufacturing and trial models that make cell therapies scalable, accessible & commercially viable.

Oncology

Cancer cell

Building a Phase I oncology centre

The question is not whether an institution should ultimately develop Phase Ia capability. It is when the organisation is ready.

Patients

Patients

Woman in yellow jacket blows nose due to hayfever

Redefining the self-care pathway in the evolving hayfever la...

When it comes to hayfever, proactive approach improves patient health literacy and empowers individuals to put their health back in their own hands.

Patients

Pharmacist hands woman prescription medicine with an explanation

Specialty medication access hinges on a 48-hour window

The vast majority of healthcare providers (HCPs) say that PA-related delays directly harm patient outcomes.

Patients

Man lies on floor next to spilled pill bottle, reference to overdose

Decline in overdose deaths ≠ The end of the opioid crisis

Since 2001, International Overdose Day has been observed as a moment to remember those lost to overdose and renew society’s commitment to

R&D

R&D

Woman in black suit extends hand of welcome to the company

Changing Faces: Pharma and biotech hires, August 2026

August brought another wave of leadership changes across biotech, pharma, and research organisations.

R&D

Female scientists compares test tubes results

Trial complexity is the new normal

When operationalised effectively, RBQM can support earlier risk detection and more targeted quality improvement.

R&D

Mosquito feeding on human skin

Mosquitoes, malaria, and UK R&D viral disease vaccine invest...

The UK must sustain investment in malaria R&D as it faces a “perfect storm” of challenges, including mosquito resistance to existing tools.

Editor's Picks

FDA overrides adcomm and approves AZ's oral SERD

Novartis falls sharply on another major R&D setback

Could UK clinical trial revamp unlock closer ties with Canada?

FDA makes acting CDER, CBER chiefs permanent

UK review recommends 'L plates' for new healthcare AIs

News

Electra sets terms for IPO, hoping to raise up to $347m

Electra sets terms for IPO, hoping to raise up to $347m

Electra Therapeutics has moved ahead with plans for an IPO, seeking to raise funds for its drug for the rare and life-threatening disease sHLH.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Digital

Discover a new era of healthcare panel engagement

Sponsored

Discover a new era of healthcare panel engagement: Grounded ...

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.

Pharmaphorum Menu

Digital
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Market Access
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Oncology
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Patients
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
R&D
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Sales & Marketing
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Spotlight on

Sign up for email newsletters and Deep Dive

Get Newsletters

youtube linkedin BlueSky

About us Advertising Contact us

Contribute Cookie Policy Privacy Policy

Terms & Conditions Work for us

The rights of trademark owners are acknowledged. Website and content copyright © 2009-2026, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – an EVERSANA company

The rights of trademark owners are acknowledged. Website and content copyright © 2009-2026, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – an EVERSANA company